Levofloxacin Kabi

Levofloxacin, the active ingredient in Levofloxacin Kabi, is a fluoroquinolone presented as an injectable solution for intravenous use. It treats a range of bacterial infections in adult patients, including community‑acquired pneumonia, acute bacterial sinusitis, skin and soft‑tissue infections, and complicated urinary tract infections.

GNH USA supplies Levofloxacin Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance across Europe, Asia, Africa and the Americas.

Levofloxacin is a fluoroquinolone antibacterial indicated for several serious bacterial infections.

- Community‑acquired bacterial pneumonia: effective treatment to eradicate the causative pathogens and improve clinical outcomes. - Acute bacterial sinusitis: helps clear infection and relieve sinus inflammation. - Skin and soft‑tissue infections: provides bacterial eradication in cellulitis, abscesses, and wound infections. - Complicated urinary tract infections: targets resistant uropathogens to resolve infection.

Levofloxacin may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or swelling, especially in the Achilles. - QT prolongation: cardiac rhythm disturbances that may lead to arrhythmia. - Severe hypersensitivity: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.

Before using Levofloxacin, consider the following precautions to ensure safe administration.

- Renal impairment: adjust dose or monitor renal function in patients with reduced kidney clearance. - History of tendon disorders: avoid in patients with prior tendon inflammation or recent corticosteroid therapy. - Cardiac risk: caution in individuals with known QT prolongation or electrolyte abnormalities. - Concomitant medications: review for drugs that may prolong QT interval or affect metabolism. - Pregnancy and lactation: use only if clearly needed, as safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with other medicines, altering its efficacy or increasing toxicity.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption; separate administration by at least 2 hours. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk; monitor INR closely. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of central nervous system stimulation and seizures.

Moderate Interactions (Monitor Closely): - Theophylline: levofloxacin can raise plasma theophylline levels; monitor for toxicity. - Cyclosporine: may increase cyclosporine concentrations; adjust dose as needed. - Diabetic agents (e.g., insulin, sulfonylureas): possible hypoglycemia; monitor blood glucose.